Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib and Everolimus in Advanced Gynecologic and Breast Cancer
NCT03154281Phase 1Completed
- Sponsor
- Avera McKennan Hospital & University Health Center
- Start
- Jul 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of niraparib in breast cancer, ovarian cancer, endometrial cancer (EC) and 2 more, sponsored by Avera McKennan Hospital & University Health Center. Started Jul 2017; status: completed.
02
Drugs
niraparib
03
Conditions
breast cancerovarian cancerendometrial cancer (EC)Cervical Cancer (CC)gynecologic malignancy
Beyond the preview
Go deeper on NCT03154281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154281.